[{"Assets_0_Q2_USD":125826000.0,"CommonStockSharesOutstanding_0_Q2_shares":44066000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-18225000.0,"NetIncomeLoss_1_Q2_USD":-19792000.0,"NetIncomeLoss_2_Q2_USD":-22636000.0,"StockholdersEquity_0_Q2_USD":88542000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]